TIL ALERT: Ongoing Investigation Into Instil Bio, Inc. - Contact Levi & Korsinsky Ready to Announce with Confidence?

New York, New York--(Newsfile Corp. - January 20, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Instil Bio, Inc. ("Instil Bio, Inc.") (NASDAQ: TIL) concerning potential violations of the federal securities laws.

Instil issued a press release on January 6, 2026, announcing that Axion Bio, Inc. ("Axion"), an Instil subsidiary, "has decided to discontinue clinical development of AXN-2510 and that Axion and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. . . . have entered into an agreement terminating their license and collaboration agreement for AXN-2510 and AXN-27M ('Termination Agreement')."

Following this news, Instil's stock price fell over 45% on January 6, 2026.

If you suffered a loss on your Instil Bio, Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

jlevi@levikorsinsky.com

Tel: (212)363-7500

Fax: (212)363-7171

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280964

Source: Levi & Korsinsky, LLP

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Levi & Korsinsky, LLP or all companies in the Banking / Financial Services industry.

TIL ALERT: Ongoing Investigation Into Instil Bio, Inc. - Contact Levi & Korsinsky

2026-01-20 3:03 PM EST

Potential Securities Fraud: Levi & Korsinsky Investigates Rezolute, Inc. (RZLT)

2026-01-19 12:47 AM EST

Ongoing Securities Investigation into Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky

2026-01-19 12:43 AM EST

Apr 30, 2025

Many public companies struggle to maintain investor visibility and engagement between earnings announcements or major financial events....

Economy, Business and Finance

Legal Service

Litigation and Regulation

Banking / Financial Services